Recent insights in the paracrine modulation of cardiomyocyte contractility by cardiac endothelial cells

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Noireaud, Jacques ^a   Andriantsitohaina, Ramaroson ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; NITRIC OXIDE; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; NRG1 PROTEIN, HUMAN;

CAPILLARY ENDOTHELIAL CELL; CARDIAC ENDOTHELIAL CELL; CELL PH; CHOLINERGIC SYSTEM; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; INOTROPISM; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PROTEIN HOMEOSTASIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HEART CONTRACTION; HEART MUSCLE CELL; HUMAN; METABOLISM; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; ENDOTHELIN-1; HUMANS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NEUREGULIN-1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PARACRINE COMMUNICATION;

EID: 84897526216     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/923805     Document Type: Review

References (127)

1. Brutsaert D. L., Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiological Reviews 2003 83 1 59 115 2-s2.0-0037207468 (Pubitemid 36459878)
2. Kuruvilla L., Kartha C. C., Molecular mechanisms in endothelial regulation of cardiac function. Molecular and Cellular Biochemistry 2003 253 1-2 113 123 2-s2.0-0142243367 10.1023/A:1026061507004 (Pubitemid 37321717)
3. Mohácsi A., Magyar J., Bányász T., Nánási P. P., Effects of endothelins on cardiac and vascular cells: new therapeutic target for the future. Current Vascular Pharmacology 2004 2 53 63 (Pubitemid 38855015)
4. Balligand J.-L., Feron O., Dessy C., eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiological Reviews 2009 89 2 481 534 2-s2.0-64749090979 10.1152/physrev.00042.2007
5. Drawnel F. M., Archer C. R., Roderick H. L., The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. British Journal of Pharmacology 2013 168 296 317
6. Andries L. J., Brutsaert D. L., Differences in structure between endocardial and vascular endothelium. Journal of Cardiovascular Pharmacology 1991 17 3 S243 S246 2-s2.0-0025783190
7. de Hert S. G., Gillebert T. C., Andries L. J., Brutsaert D. L., Role of the endocardial endothelium in the regulation of myocardial function: physiologic and pathophysiologic implications. Anesthesiology 1993 79 6 1354 1366 2-s2.0-0027142554 (Pubitemid 24005783)
8. Brutsaert D. L., Fransen P., Andries L. J., de Keulenaer G. W., Sys S. U., Cardiac endothelium and myocardial function. Cardiovascular Research 1998 38 2 281 290 2-s2.0-0032076220 10.1016/S0008-6363(98)00044-3 (Pubitemid 28294146)
9. Brutsaert D. L., de Keulenaer G. W., Fransen P., Mohan P., Kaluza G. L., Andries L. J., Rouleau J.-L., Sys S. U., The cardiac endothelium: functional morphology, development, and physiology. Progress in Cardiovascular Diseases 1996 39 3 239 262 2-s2.0-0030474916 10.1016/S0033-0620(96)80004-1 (Pubitemid 26424610)
10. Sowa G., Caveolae, caveolins, cavins, and endothelial cell function: new insights. Frontiers in Physiology 2012 2 1 13
11. Andries L. J., Brutsaert D. L., Sys S. U., Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circulation Research 1998 82 2 195 203 2-s2.0-0032498529 (Pubitemid 28080102)
12. Balligand J.-L., Kobzik L., Han X., Kaye D. M., Belhassen L., O'Hara D. S., Kelly R. A., Smith T. W., Michel T., Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. The Journal of Biological Chemistry 1995 270 24 14582 14586 2-s2.0-0029057806 10.1074/jbc.270.24.14582
13. Zhang Q., Church J. E., Jagnandan D., Catravas J. D., Sessa W. C., Fulton D., Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 5 1015 1021 2-s2.0-33646451361 10.1161/01.ATV. 0000216044.49494.c4 (Pubitemid 43732106)
14. Qian J., Zhang Q., Church J. E., Stepp D. W., Rudic R. D., Fulton D. J. R., Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation. The American Journal of Physiology-Heart and Circulatory Physiology 2010 298 1 H112 H118 2-s2.0-73549093794 10.1152/ajpheart.00614.2009
15. Michel J. B., Feron O., Sase K., Prabhakar P., Michel T., Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. The Journal of Biological Chemistry 1997 272 41 25907 25912 2-s2.0-0030770629 10.1074/jbc.272.41.25907 (Pubitemid 27438916)
16. Rizzo V., McIntosh D. P., Oh P., Schnitzer J. E., In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. The Journal of Biological Chemistry 1998 273 52 34724 34729 2-s2.0-0032567415 10.1074/jbc.273.52.34724 (Pubitemid 29028162)
17. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F. C., Schedl A., Hailer H., Kurzchalia T. V., Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001 293 5539 2449 2452 2-s2.0-0035964954 10.1126/science.1062688 (Pubitemid 32917325)
18. Razani B., Engelman J. A., Wang X. B., Schubert W., Zhang X. L., Marks C. B., Macalusol F., Russell R. G., Li M., Pestell R. G., Di Vizio D., Hou H. Jr., Kneitz B., Lagaud G., Christ G. J., Edelmann W., Lisanti M. P., Caveolin-1 Null mice are viable but show evidence of hyperproliferative and vascular abnormalities. The Journal of Biological Chemistry 2001 276 41 38121 38138 2-s2.0-0035851197
19. Feron O., Dessy C., Desager J.-P., Balligand J.-L., Hydroxy- methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease caveolin abundance. Circulation 2001 103 1 113 118 2-s2.0-0035830412 (Pubitemid 32050445)
20. Dedio J., König P., Wohlfart P., Schroeder C., Kummer W., Müller-Esterl W., NOSIP, a novel modulator of endothelial nitric oxide synthase activity. The FASEB Journal 2001 15 1 79 89 2-s2.0-0035161894 10.1096/fj.00-0078com (Pubitemid 32061658)
21. Richter K., Buchner J., Hsp90: chaperoning signal transduction. Journal of Cellular Physiology 2001 188 3 281 290 2-s2.0-0034892432 10.1002/jcp.1131 (Pubitemid 32777169)
22. García-Cardeña G., Fan R., Shah V., Sorrentino R., Cirino G., Papapetropoulos A., Sessa W. C., Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998 392 6678 821 824 2-s2.0-0009621605 10.1038/33934 (Pubitemid 28225323)
23. Balligand J.-L., Heat shock protein 90 in endothelial nitric oxide synthase signaling: following the lead(er)? Circulation Research 2002 90 8 838 841 2-s2.0-0037013165 10.1161/01.RES.0000018173.10175.FF (Pubitemid 34633873)
24. Massion P. B., Balligand J.-L., Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. Journal of Physiology 2003 546 1 63 76 2-s2.0-0037232585 10.1113/jphysiol.2002.025973 (Pubitemid 36104972)
25. Fischmeister R., Castro L., Abi-Gerges A., Rochais F., Vandecasteele G., Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Comparative Biochemistry and Physiology-A Molecular and Integrative Physiology 2005 142 2 136 143 2-s2.0-26644447370 10.1016/j.cbpb.2005.04.012 (Pubitemid 41443573)
26. Vila-Petroff M. G., Younes A., Egan J., Lakatta E. G., Sollott S. J., Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circulation Research 1999 84 9 1020 1031 2-s2.0-0033553404 (Pubitemid 29227681)
27. Wegener J. W., Gödecke A., Schrader J., Nawrath H., Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice. British Journal of Pharmacology 2002 136 3 415 420 2-s2.0-0036016112 (Pubitemid 34620522)
28. Brady A. J. B., Warren J. B., Poole-Wilson P. A., Williams T. J., Harding S. E., Nitric oxide attenuates cardiac myocyte contraction. The American Journal of Physiology-Heart and Circulatory Physiology 1993 265 1 H176 H182 2-s2.0-0027279501 (Pubitemid 23224707)
29. Hobbs A. J., Soluble guanylate cyclase: the forgotten sibling. Trends in Pharmacological Sciences 1997 18 12 484 491 2-s2.0-0031435306 10.1016/S0165-6147(97)01137-1 (Pubitemid 28051766)
30. Layland J., Li J.-M., Shah A. M., Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. Journal of Physiology 2002 540 2 457 467 2-s2.0-0037092333 10.1113/jphysiol.2001.014126 (Pubitemid 35190124)
31. Abi-Gerges N., Szabo G., Otero A. S., Fischmeister R., Méry P.-F., NO donors potentiate the β -adrenergic stimulation of I C a, L and the muscarinic activation of I K, A C h in rat cardiac myocytes. Journal of Physiology 2002 540 2 411 424 2-s2.0-0037092237 10.1113/jphysiol.2001.012929 (Pubitemid 35190120)
32. Campbell D. L., Stamler J. S., Strauss H. C., Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual mechanism regulation by nitric oxide and S-nitrosothiols. Journal of General Physiology 1996 108 4 277 293 2-s2.0-0029743817 (Pubitemid 26332539)
33. Malan D., Levi R. C., Alloatti G., Marcantoni A., Bedendi I., Gallo M. P., Cyclic AMP and cyclic GMP independent stimulation of ventricular calcium current by peroxynitrite donors in guinea pig myocytes. Journal of Cellular Physiology 2003 197 2 284 296 2-s2.0-0242348817 10.1002/jcp.10368 (Pubitemid 37485257)
34. Chesnais J.-M., Fischmeister R., Méry P.-F., Peroxynitrite is a positive inotropic agent in atrial and ventricular fibres of the frog heart. Journal of Physiology 1999 521 2 375 388 2-s2.0-0033429327 (Pubitemid 30003919)
35. Ronson R. S., Nakamura M., Vinten-Johansen J., The cardiovascular effects and implications of peroxynitrite. Cardiovascular Research 1999 44 1 47 59 2-s2.0-0033215190 10.1016/S0008-6363(99)00184-4 (Pubitemid 29431683)
36. Stamler J. S., Lamas S., Fang F. C., Nitrosylation: the prototypic redox-based signaling mechanism. Cell 2001 106 6 675 683 2-s2.0-0035929149 10.1016/S0092-8674(01)00495-0 (Pubitemid 32900659)
37. Hess D. T., Matsumoto A., Kim S.-O., Marshall H. E., Stamler J. S., Protein S-nitrosylation: purview and parameters. Nature Reviews Molecular Cell Biology 2005 6 2 150 166 2-s2.0-13444282230 10.1038/nrm1569 (Pubitemid 40215810)
38. Pacher P., Beckman J. S., Liaudet L., Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 2007 87 1 315 424 2-s2.0-33846863589 10.1152/physrev.00029.2006 (Pubitemid 46217686)
39. Martínez M. C., Andriantsitohaina R., Reactive nitrogen species: molecular mechanisms and potential significance in health and disease. Antioxidants & Redox Signaling 2009 11 3 669 702 2-s2.0-58849158293 10.1089/ars.2007.1993
40. Lima B., Forrester M. T., Hess D. T., Stamler J. S., S-nitrosylation in cardiovascular signaling. Circulation Research 2010 106 4 633 646 2-s2.0-77949370996 10.1161/CIRCRESAHA.109.207381
41. Kohr M. J., Aponte A. M., Sun J., Wang G., Murphy E., Gucek M., Steenbergen C., Characterization of potential S-nitrosylation sites in the myocardium. The American Journal of Physiology-Heart and Circulatory Physiology 2011 300 4 H1327 H1335 2-s2.0-79955058871 10.1152/ajpheart.00997.2010
42. 2+ release in cardiomyocytes. Nature Cell Biology 2001 3 10 867 873 2-s2.0-0034785189 10.1038/ncb1001-867 (Pubitemid 32952250)
43. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. The Journal of Biological Chemistry 1993 268 35 26286 26295 2-s2.0-0027495714 (Pubitemid 23361700)
44. Rochais F., Vandecasteele G., Lefebvre F., Lugnier C., Lum H., Mazet J.-L., Cooper D. M. F., Fischmeister R., Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels. The Journal of Biological Chemistry 2004 279 50 52095 52105 2-s2.0-10644280705 10.1074/jbc.M405697200 (Pubitemid 39656582)
45. Keravis T., Lugnier C., Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments. British Journal of Pharmacology 2012 165 5 1288 1305 2-s2.0-84857080656 10.1111/j.1476-5381.2011.01729.x
46. Kedzierski R. M., Yanagisawa M., Endothelin system: the double-edged sword in health and disease. Annual Review of Pharmacology and Toxicology 2001 41 851 876 2-s2.0-0035040924 10.1146/annurev.pharmtox.41.1.851 (Pubitemid 32385909)
47. Molenaar P., O'Reilly G., Sharkey A., Kuc R. E., Harding D. P., Plumpton C., Gresham G. A., Davenport A. P., Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circulation Research 1993 72 3 526 538 2-s2.0-0027538163 (Pubitemid 23052151)
48. 2+ in human endocardial endothelium. Journal of Cardiovascular Pharmacology 2000 36 5 S397 S400 2-s2.0-0033743871 10.1097/00005344-200000006-00001
49. Li K., Stewart D. J., Rouleau J.-L., Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles: role of endocardial endothelium. Circulation Research 1991 69 2 301 312 2-s2.0-0025739843
50. Mebazaa A., Mayoux E., Maeda K., Martin L. D., Lakatta E. G., Robotham J. L., Shah A. M., Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. The American Journal of Physiology-Heart and Circulatory Physiology 1993 265 5 H1841 H1846 2-s2.0-0027134993
51. 2+ responsiveness in aequorin-loaded ferret myocardium. Circulation Research 1991 69 3 582 589 2-s2.0-0025994960
52. + exchanger. Circulation Research 1991 68 1 269 279 2-s2.0-0026008445
53. Luscher T. F., Boulanger C. M., Yang Z., Noll G., Dohi Y., Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993 87 5 V36 V44 2-s2.0-0027286240 (Pubitemid 23135668)
54. Kubin A.-M., Skoumal R., Tavi P., Kónyi A., Perjés Á., Leskinen H., Ruskoaho H., Szokodi I., Role of reactive oxygen species in the regulation of cardiac contractility. Journal of Molecular and Cellular Cardiology 2011 50 5 884 893 2-s2.0-79953700537 10.1016/j.yjmcc.2011.02.005
55. Szokodi I., Kerkelä R., Kubin A.-M., Sármán B., Pikkarainen S., Kónyi A., Horváth I. G., Papp L., Tóth M., Skoumal R., Ruskoaho H., Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility. Circulation 2008 118 16 1651 1658 2-s2.0-55949117098 10.1161/CIRCULATIONAHA.107.758623
56. Zima A. V., Blatter L. A., Redox regulation of cardiac calcium channels and transporters. Cardiovascular Research 2006 71 2 310 321 2-s2.0-33745198418 10.1016/j.cardiores.2006.02.019
57. Santos C. X. C., Anilkumar N., Zhang M., Brewer A. C., Shah A. M., Redox signaling in cardiac myocytes. Free Radical Biology and Medicine 2011 50 7 777 793 2-s2.0-79952041217 10.1016/j.freeradbiomed.2011.01.003
58. Heinzel F. R., Luo Y., Dodoni G., Boengler K., Petrat F., Di Lisa F., de Groot H., Schulz R., Heusch G., Formation of reactive oxygen species at increased contraction frequency in rat cardiomyocytes. Cardiovascular Research 2006 71 2 374 382 2-s2.0-33745194661 10.1016/j.cardiores.2006.05.014
59. Saitoh S.-I., Zhang C., Tune J. D., Potter B., Kiyooka T., Rogers P. A., Knudson J. D., Dick G. M., Swafford A., Chilian W. M., Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 12 2614 2621 2-s2.0-33751183752 10.1161/01.ATV.0000249408.55796.da
60. Cingolani H. E., Villa-Abrille M. C., Cornelli M., Nolly A., Ennis I. L., Garciarena C., Suburo A. M., Torbidoni V., Correa M. V., Camilión De Hurtado M. C., Aiello E. A., The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. Hypertension 2006 47 4 727 734 2-s2.0-33645822732 10.1161/01.HYP.0000208302.62399.68 (Pubitemid 43740245)
61. de Giusti V. C., Correa M. V., Villa-Abrille M. C., Beltrano C., Yeves A. M., de Cingolani G. E. C., Cingolani H. E., Aiello E. A., The positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen species. Life Sciences 2008 83 7-8 264 271 2-s2.0-48549106437 10.1016/j.lfs.2008.06.008
62. 2+ signaling in intact myocardium. Journal of Pharmacological Sciences 2006 100 5 525 537 2-s2.0-33747588571 10.1254/jphs.CPJ06009X (Pubitemid 44609542)
63. Brunner F., Brás-Silva C., Cerdeira A. S., Leite-Moreira A. F., Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacology and Therapeutics 2006 111 2 508 531 2-s2.0-33744784032 10.1016/j.pharmthera.2005.11.001 (Pubitemid 43832003)
64. 2+ transients and cell shortening in mouse ventricular myocytes. Journal of Molecular and Cellular Cardiology 2008 44 3 520 526 2-s2.0-40649108033 10.1016/j.yjmcc.2007.12.007
65. Carter T. D., Pearson J. D., Regulation of prostacyclin synthesis in endothelial cells. NIPS 1992 7 64 69
66. Gerritsen M. E., Physiological and pathophysiological roles of eicosanoids in the microcirculation. Cardiovascular Research 1996 32 4 720 732 2-s2.0-0030270063 10.1016/0008-6363(96)00072-7 (Pubitemid 26332311)
67. Mebazaa A., Wetzel R., Cherian M., Abraham M., Comparison between endocardial and great vessel endothelial cells: morphology, growth, and prostaglandin release. The American Journal of Physiology-Heart and Circulatory Physiology 1995 268 1 H250 H259 2-s2.0-0028869420
68. 2+ transients in individual rat ventricular myocytes. The American Journal of Physiology-Heart and Circulatory Physiology 1997 272 1 H350 H359 2-s2.0-0031023252
69. Couttenye M. M., de Clerck N. M., Herman A. G., Brutsaert D. L., Effects of prostacyclin on contractile properties of isolated mammalian cardiac muscle. Journal of Cardiovascular Pharmacology 1985 7 5 971 976 2-s2.0-0021933796 (Pubitemid 15235165)
70. Schror K., Hohlfeld T., Inotropic actions of eicosanoids. Basic Research in Cardiology 1992 87 1 2 11 2-s2.0-0026558472
71. Mohan P., Brutsaert D. L., Sys S. U., Myocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandins. Cardiovascular Research 1995 29 5 637 640 2-s2.0-0029055233 10.1016/0008- 6363(96)88633-0
72. Hendrickson R. J., Cappadona C., Yankah E. N., Sitzmann J. V., Cahill P. A., Redmond E. M., Sustained pulsatile flow regulates endothelial nitric oxide synthase and cyclooxygenase expression in co-cultured vascular endothelial and smooth muscle cells. Journal of Molecular and Cellular Cardiology 1999 31 3 619 629 2-s2.0-0033106125 10.1006/jmcc.1998.0898 (Pubitemid 29121647)
73. Klumpp G., Schildknecht S., Nastainczyk W., Ullrich V., Bachschmid M., Prostacyclin in the cardiovascular system: new aspects and open questions. Pharmacological Reports 2005 57 S120 S126 2-s2.0-33645671210
74. Nishimaru K., Tanaka Y., Tanaka H., Shigenobu K., Positive and negative inotropic effects of muscarinic receptor stimulation in mouse left atria. Life Sciences 2000 66 7 607 615 2-s2.0-0034614329 10.1016/S0024-3205(99)00633-5 (Pubitemid 30055404)
75. Tanaka H., Nishimaru K., Kobayashi M., Matsuda T., Tanaka Y., Shigenobu K., Acetylcholine-induced positive inotropy mediated by prostaglandin released from endocardial endothelium in mouse left atrium. Naunyn-Schmiedeberg's Archives of Pharmacology 2001 363 5 577 582 2-s2.0-0035023027 10.1007/s002100100411 (Pubitemid 32417817)
76. Fong Yew S., Reeves K. A., Woodward B., Effects of prostaglandin F(2 α) on intracellular pH, intracellular calcium, cell shortening and L-type calcium currents in rat myocytes. Cardiovascular Research 1998 40 3 538 545 2-s2.0-0032242365 10.1016/S0008-6363(98)00195-3 (Pubitemid 28557295)
77. Tanaka H., Nishimaru K., Makuta R., Hirayama W., Kawamura T., Matsuda T., Tanaka Y., Kawanishi T., Shigenobu K., Possible involvement of prostaglandins F2 α and D2 in acetylcholine-induced positive inotropy in isolated mouse left atria. Pharmacology 2003 67 3 157 162 2-s2.0-0037262891 10.1159/000067794 (Pubitemid 36184461)
78. Dzau V. J., Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988 77 6 4 13 2-s2.0-0023922776
79. Sakurai K., Norota I., Tanaka H., Kubota I., Tomoike H., Endoh M., Negative inotropic effects of angiotensin II, endothelin-1 and phenylephrine in indo-1 loaded adult mouse ventricular myocytes. Life Sciences 2002 70 10 1173 1184 2-s2.0-0037169275 10.1016/S0024-3205(01)01497-7 (Pubitemid 34137085)
80. Scott A. L., Chang R. S. L., Lotti V. J., Siegl P. K. S., Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart. Journal of Pharmacology and Experimental Therapeutics 1992 261 3 931 935 2-s2.0-0026637278
81. Schomisch Moravec C., Schluchter M. D., Paranandi L., Czerska B., Stewart R. W., Rosenkranz E., Bond M., Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation 1990 82 6 1973 1984 2-s2.0-0025681914
82. Holubarsch C., Hasenfuss G., Schmidt-Schweda S., Knorr A., Pieske B., Ruf T., Fasol R., Just H., Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium: an in vitro study under physiological experimental conditions. Circulation 1993 88 3 1228 1237 2-s2.0-0027291588 (Pubitemid 23264043)
83. Wenzel S., Taimor G., Piper H. M., Schlüter K. D., Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. The FASEB Journal 2001 15 12 2291 2293 2-s2.0-0035487975
84. Grieve D. J., Byrne J. A., Siva A., Layland J., Johar S., Cave A. C., Shah A. M., Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. Journal of the American College of Cardiology 2006 47 4 817 826 2-s2.0-32644447208 10.1016/j.jacc.2005.09.051 (Pubitemid 43243107)
85. Taimor G., Schlüter K.-D., Piper H. M., Hypertrophy-associated gene induction after β -adrenergic stimulation in adult cardiomyocytes. Journal of Molecular and Cellular Cardiology 2001 33 3 503 511 2-s2.0-0034970778 10.1006/jmcc.2000.1324 (Pubitemid 32539006)
86. Schröder D., Heger J., Piper H. M., Euler G., Angiotensin II stimulates apoptosis via TGF- β 1 signaling in ventricular cardiomyocytes of rat. Journal of Molecular Medicine 2006 84 11 975 983 2-s2.0-33750490112 10.1007/s00109-006-0090-0 (Pubitemid 44655875)
87. Mufti S., Wenzel S., Euler G., Piper H. M., Schlüter K.-D., Angiotensin II-dependent loss of cardiac function: mechanisms and pharmacological targets attenuating this effect. Journal of Cellular Physiology 2008 217 1 242 249 2-s2.0-49649128837 10.1002/jcp.21501
88. Palomeque J., Sapia L., Hajjar R. J., Mattiazzi A., Vila Petroff M., Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. The American Journal of Physiology-Heart and Circulatory Physiology 2006 290 1 H96 H106 2-s2.0-33644789089 10.1152/ajpheart.00324.2005
89. Sabri A., Lucchesi P. A., ANG II and cardiac myocyte contractility: p38 is not stressed out! The American Journal of Physiology-Heart and Circulatory Physiology 2006 290 1 H72 H73 2-s2.0-33644796961 10.1152/ajpheart.00873.2005
90. de Giusti V. C., Caldiz C. I., Ennis I. E., Pérez N. G., Cingolani H. E., Aiello E. A., Mitochondrial reactive oxygen species (ROS) as signaling molecules of intracellular pathways triggered by the cardiac renin-angiotensin II-aldosterone system (RAAS). Frontiers in Physiology 2013 4 1 9
91. +- H C O 3-Co-transport. Journal of Cardiovascular Electrophysiology 2006 17 1 S134 S140 2-s2.0-33646010354 10.1111/j.1540-8167. 2006.00394.x
92. 2+ exchange after myocardial stretch: underlying mechanism of the slow force response. Circulation Research 2001 88 4 376 382 2-s2.0-0035793924 (Pubitemid 32200109)
93. 1/2 MAP kinases: role for an NHE-1-dependent pathway. The American Journal of Physiology-Heart and Circulatory Physiology 2002 283 2 H598 H605 2-s2.0-0036073006 (Pubitemid 34790854)
94. Bril A., Ion transporters and cardiovascular diseases: pH control or modulation of intracellular calcium concentration. Annales de Cardiologie et d'Angeiologie 2003 52 1 41 51 2-s2.0-0037300311 10.1016/S0003-3928(02)00182-8 (Pubitemid 36358682)
95. Morgan P. E., Correa M. V., Ennis I. E., Diez A. A., Pérez N. G., Cingolani H. E., Silencing of sodium/hydrogen exchanger in the heart by direct injection of naked siRNA. Journal of Applied Physiology 2011 111 2 566 572 2-s2.0-80051731498 10.1152/japplphysiol.00200.2011
96. Schlüter K.-D., PTH and PTHrP: similar structures but different functions. News in Physiological Sciences 1999 14 6 243 248 2-s2.0-0040714211
97. Schlüter K.-D., Katzer C., Frischkopf K., Wenzel S., Taimor G., Piper H. M., Expression, release, and biological activity of parathyroid hormone- related peptide from coronary endothelial cells. Circulation Research 2000 86 9 946 951 2-s2.0-0034640535 (Pubitemid 30324306)
98. Jansen J., Gres P., Umschlag C., Heinzel F. R., Degenhardt H., Schlüter K.-D., Heusch G., Schulz R., Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs. The American Journal of Physiology-Heart and Circulatory Physiology 2003 284 1 H49 H55 2-s2.0-0037235167 (Pubitemid 36076269)
99. Schlüter K.-D., Weber M., Piper H. M., Effects of PTHrP(107-111) and PTHrP(7-34) on adult cardiomyocytes. Journal of Molecular and Cellular Cardiology 1997 29 3057 3065 (Pubitemid 27510772)
100. Schreckenberg R., Wenzel S., Rebelo R. M. D. C., Röthig A., Meyer R., Schlüter K.-D., Cell-specific effects of nitric oxide deficiency on parathyroid hormone-related peptide (PTHrP) responsiveness and PTH1 receptor expression in cardiovascular cells. Endocrinology 2009 150 8 3735 3741 2-s2.0-67651176097 10.1210/en.2008-1585
101. Parodi E. M., Kuhn B., Signaling between microvascular endothelium and cardiomyocytes through neuregulin. Cardiovascular Research 2014 10.1093/cvr/cvu021
102. Holbro T., Hynes N. E., ErbB receptors: directing key signaling networks throughout life. Annual Review of Pharmacology and Toxicology 2004 44 195 217 2-s2.0-1342323632 10.1146/annurev.pharmtox.44.101802.121440 (Pubitemid 38263839)
103. Burden S., Yarden Y., Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 1997 18 6 847 855 2-s2.0-0030919509 10.1016/S0896-6273(00)80324-4 (Pubitemid 27274603)
104. Schneider J. W., Chang A. Y., Garratt A., Trastuzumab cardiotoxicity: speculations regarding pathophysiology and targets for further study. Seminars in Oncology 2002 29 3 22 28 2-s2.0-0036316232 (Pubitemid 34816062)
105. Falls D. L., Neuregulins: functions, forms, and signaling strategies. Experimental Cell Research 2003 284 1 14 30 2-s2.0-0037429649 10.1016/S0014-4827(02)00102-7 (Pubitemid 36335807)
106. Garratt A. N., Özcelik C., Birchmeier C., ErbB2 pathways in heart and neural diseases. Trends in Cardiovascular Medicine 2003 13 2 80 86 2-s2.0-0037312369 10.1016/S1050-1738(02)00231-1 (Pubitemid 36173861)
107. Crone S. A., Zhao Y.-Y., Fan L., Gu Y., Minamisawa S., Liu Y., Peterson K. L., Chen J., Kahn R., Condorelli G., Ross J. Jr., Chien K. R., Lee K.-F., ErbB2 is essential in the prevention of dilated cardiomyopathy. Nature Medicine 2002 8 5 459 465 2-s2.0-0036099675 10.1038/nm0502-459 (Pubitemid 34546747)
108. Özcelik C., Erdmann B., Pilz B., Wettschureck N., Britsch S., Hübner N., Chien K. R., Birchmeier C., Garratt A. N., Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America 2002 99 13 8880 8885 2-s2.0-0037172982 10.1073/pnas.122249299 (Pubitemid 34693652)
109. Ueda H., Oikawa A., Nakamura A., Terasawa F., Kawagishi K., Moriizumi T., Neuregulin receptor ErbB2 localization at T-tubule in cardiac and skeletal muscle. Journal of Histochemistry and Cytochemistry 2005 53 1 87 91 2-s2.0-12344312470 10.1369/jhc.4A6341.2005 (Pubitemid 40130123)
110. Lemmens K., Fransen P., Sys S. U., Brutsaert D. L., de Keulenaer G. W., Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase. Circulation 2004 109 3 324 326 2-s2.0-1642458136 10.1161/01.CIR.0000114521.88547.5E (Pubitemid 38133898)
111. Fleming I., Busse R., Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2003 284 1 R1 R12 2-s2.0-0037216768 (Pubitemid 36008649)
112. Lemmens K., Segers V. F. M., Demolder M., de Keulenaer G. W., Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk. The Journal of Biological Chemistry 2006 281 28 19469 19477 2-s2.0-33745805840 10.1074/jbc.M600399200 (Pubitemid 44035451)
113. Seddon M., Shah A. M., Casadei B., Cardiomyocytes as effectors of nitric oxide signalling. Cardiovascular Research 2007 75 2 315 326 2-s2.0-34250790280 10.1016/j.cardiores.2007.04.031 (Pubitemid 46961933)
114. Manoury B., Montiel V., Balligand J.-L., Nitric oxide synthase in post-ischaemic remodelling: new pathways and mechanisms. Cardiovascular Research 2012 94 2 304 315 2-s2.0-84860137298 10.1093/cvr/cvr360
115. Carnicer R., Crabtree M. J., Sivakumaran V., Casadei B., Kass D. A., Nitric oxide synthases in heart failure. Antioxidants & Redox Signaling 2013 18 1078 1099
116. Rakhit A., Maguire C. T., Wakimoto H., Gehrmann J., Li G. K., Kelly R. A., Michel T., Berul C. I., In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice. Journal of Cardiovascular Electrophysiology 2001 12 11 1295 1301 2-s2.0-0035198036 (Pubitemid 33111900)
117. 2+ current. The American Journal of Physiology-Heart and Circulatory Physiology 2008 294 3 H1473 H1480 2-s2.0-41549122317 10.1152/ajpheart.01249.2007 (Pubitemid 351468748)
118. Barouch L. A., Harrison R. W., Skaf M. W., Rosas G. O., Cappola T. P., Kobeissi Z. A., Hobai I. A., Lemmon C. A., Burnett A. L., O'Rourke B., Rodriguez E. R., Huang P. L., Lima J. A. C., Berkowitz D. E., Hare J. M., Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002 416 6878 337 339 2-s2.0-0037149489 10.1038/416005a (Pubitemid 34260250)
119. Scherrer-Crosbie M., Ullrich R., Bloch K. D., Nakajima H., Nasseri B., Aretz H. T., Lindsey M. L., Vançon A.-C., Huang P. L., Lee R. T., Zapol W. M., Picard M. H., Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 2001 104 11 1286 1291 2-s2.0-0035845630 (Pubitemid 32848119)
120. Ruetten H., Dimmeler S., Gehring D., Ihling C., Zeiher A. M., Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovascular Research 2005 66 3 444 453 2-s2.0-19444372119 10.1016/j.cardiores.2005.01.021 (Pubitemid 40725756)
121. Takimoto E., Champion H. C., Li M., Ren S., Rodriguez E. R., Tavazzi B., Lazzarino G., Paolocci N., Gabrielson K. L., Wang Y., Kass D. A., Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. Journal of Clinical Investigation 2005 115 5 1221 1231 2-s2.0-20944445197 10.1172/JCI200521968 (Pubitemid 40629040)
122. Torfgard K. E., Ahlner J., Mechanisms of action of nitrates. Cardiovascular Drugs and Therapy 1994 8 5 701 717 2-s2.0-0028062774 10.1007/BF00877117 (Pubitemid 24376750)
123. Kollau A., Beretta M., Russwurm M., Koesling D., Keung W. M., Schmidt K., Mayer B., Mitochondrial nitrite reduction coupled to soluble guanylate cyclase activation: lack of evidence for a role in the bioactivation of nitroglycerin. Nitric Oxide-Biology and Chemistry 2009 20 1 53 60 2-s2.0-55549128187 10.1016/j.niox.2008.09.003
124. Kollau A., Hofer A., Russwurm M., Koesling D., Keung W. M., Schmidt K., Brunner F., Mayer B., Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide. Biochemical Journal 2005 385 3 769 777 2-s2.0-13444273181 10.1042/BJ20041354 (Pubitemid 40208838)
125. Kirkby N. S., Hadoke P. W. F., Bagnall A. J., Webb D. J., The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? British Journal of Pharmacology 2008 153 6 1105 1119 2-s2.0-40949132561 10.1038/sj.bjp.0707516 (Pubitemid 351415492)
126. Gomberg-Maitland M., Dufton C., Oudiz R. J., Benza R. L., Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective. Journal of the American College of Cardiology 2011 57 9 1053 1061 2-s2.0-79951996862 10.1016/j.jacc.2010.11.020
127. D'Autréaux B., Toledano M. B., ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature Reviews Molecular Cell Biology 2007 8 813 824 (Pubitemid 47462134)